Salesforce Shows M&A Is Coming Back. What It Means for Investors.
Latest News
- Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering
- Bernstein Raises Salesforce (CRM) Price Target to $255, Keeps Underperform Rating
- Elbit Systems Ltd. (ESLT) Secures $330M in Naval Defense Contracts
- Morgan Stanley Lifts Salesforce, Inc. (CRM)’s Price Target to $404, Maintains Overweight Rating
- Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests
- Watch These Boeing Price Levels After Stock Jumps to Highest Level in 15 Months